|
biomedicina slovenica |
pr=Amir : 89
-
Adam Roman; Tibau Martorell Ariadna; Molto Valiente Consolación; Šeruga Boštjan; Ocaña Alberto; Amir Eitan; Templeton Arnoud J.
Clinical benefit of cancer drugs approved in Switzerland 2010‐2019
2022 ►
-
Lohmann Ana Elisa; Soldera Sara V.; Pimentel Isabel; Ribnikar Domen; Ennis Marguerite; Amir Eitan; Goodwin Pamela J.
Association of obesity with breast cancer outcome in relation to cancer subtypes
2021 ►
-
Deneau Mark R.; Mack Cara; Perito Emily R.; Ricciuto Amanda; Valentino Pamela L.; Amin Mansi; Amir Achiya; Aumar Madeleine; Auth Marcus; Broderick Annemarie; Homan Matjaž
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) index
2021 ►
-
Ribnikar Domen; Stukalin Igor; Bedard Philippe L.; Hamilton Robert J.; Jewett Michael; Warde Padraig; Chung Peter; Templeton Arnoud J.; Amir Eitan; Lewin Jeremy
The prognostic value of neutrophil-to-lymphocyte ratio in metastatic testicular cancer
2020 ►
-
Gonzales-Conchas Galileo A.; Rodríguez-Romo L.; Hernandez-Barajas D.; Fernández-Rodríguez A.; Hernandez Adrian F.; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Tannock Ian F.; Amir Eitan
Epidermal growth factor receptor overexpression and outcomes in early breast cancer
2018 ►
-
Saleh Ramy R.; Meti Nicholas; Ribnikar Domen; Goldvaser Hadar; Ocaña Alberto; Templeton Arnoud J.; Šeruga Boštjan; Amir Eitan
Associations between safety, tolerability, and toxicity and the reporting of health-related quality of life in phase III randomized trials in common solid tumors
2020 ►
-
Šeruga Boštjan; Amir Eitan; Tannock Ian F.
Hormonal anticancer treatment in the senior cancer patient
2015 ►
-
Fernández-Rodríguez A.; Rodríguez-Romo L.; Hernandez-Barajas D.; Gonzalez-Conchas G. A.; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Tannock Ian F.; Amir Eitan; Vera-Badillo Francisco Emilio
Adjuvant radiation therapy after radical nephrectomy in patients with localized renal cell carcinoma
2019 ►
-
Deneau Mark R.; Mack Cara; Abdou Reham; Amin Mansi; Amir Achiya; Auth Marcus; Bazerbachi Fateh; Broderick Annemarie; Chan Albert; DiGuglielmo Matthew; Homan Matjaž
Gamma glutamyltransferase reduction is associated with favorable outcomes in pediatric primary sclerosing cholangitis
2018 ►
-
Shepshelovich Daniel; Tibau Martorell Ariadna; Goldvaser Hadar; Molto Valiente Consolación; Ocaña Alberto; Šeruga Boštjan; Amir Eitan
Postmarketing modifications of drug labels for cancer drugs approved by the US Food and Drug Administration between 2006 and 2016 with and without supporting randomized controlled trials
2018 ►
-
Algorashi Ibrahim; Goldvaser Hadar; Ribnikar Domen; Cescon David W.; Amir Eitan
Evolution in sites of recurrence over time in breast cancer patients treated with adjuvant endocrine therapy
2018 ►
-
Goldvaser Hadar; Ribnikar Domen; Majeed Habeeb; Ocaña Alberto; Amir Eitan
Absolute benefit from adjuvant chemotherapy in contemporary clinical trials
2018 ►
-
Goldvaser Hadar; Algorashi Ibrahim; Ribnikar Domen; Šeruga Boštjan; Templeton Arnoud J.; Ocaña Alberto; Amir Eitan
Efficacy of extended adjuvant therapy with aromatase inhibitors in early breast cancer among common clinicopathologically-defined subgroups
2017 ►
-
Goldvaser Hadar; Majeed Habeeb; Ribnikar Domen; Šeruga Boštjan; Ocaña Alberto; Cescon David W.; Amir Eitan
Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer
2018 ►
-
Ribnikar Domen; Goldvaser Hadar; Ocaña Alberto; Templeton Arnoud J.; Šeruga Boštjan; Amir Eitan
Reporting of randomized trials in common cancers in the lay media
2018 ►
-
Barua Reeta; Templeton Arnoud J.; Šeruga Boštjan; Ocaña Alberto; Amir Eitan; Ethier Josee-Lyne
Hyperglycaemia and survival in solid tumours
2018 ►
-
Goldvaser Hadar; Barnes Tristan A.; Šeruga Boštjan; Cescon David W.; Ocaña Alberto; Ribnikar Domen; Amir Eitan
Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer
2018 ►
-
Barnes Tristan A.; Amir Eitan; Templeton Arnoud J.; Gomez-Garcia Susana; Navarro Beatriz; Šeruga Boštjan; Ocaña Alberto
Efficacy, safety, tolerability and price of newly approved drugs in solid tumors
2017 ►
-
Vera-Badillo Francisco Emilio; Napoleone Marc; Krzyzanowska Monika K.; Alibhai Shabbir M.; Chan An-Wen; Ocaña Alberto; Templeton Arnoud J.; Šeruga Boštjan; Amir Eitan; Tannock Ian F.
Honorary and ghost authorship in reports of randomised clinical trials in oncology
2016 ►
-
Adam Roman; Díez-González Laura; Ocaña Alberto; Šeruga Boštjan; Amir Eitan; Templeton Arnoud J.
Prognostic role of telomere length in malignancies
2017 ►
-
Goldvaser Hadar; Ribnikar Domen; Fazelzad Rouhi; Šeruga Boštjan; Templeton Arnoud J.; Ocaña Alberto; Amir Eitan
Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer
2017 ►
-
Tibau Martorell Ariadna; Díez-González Laura; Navarro Beatriz; Galán-Moya Eva M.; Templeton Arnoud J.; Šeruga Boštjan; Pandiella Atanasio; Amir Eitan; Ocaña Alberto
Impact of availability of companion diagnostics on the clinical development of anticancer drugs
2017 ►
-
Ribnikar Domen; Ratoša Ivica; Perhavec Andraž; Amir Eitan
General overview and treatment recommendations for young women with breast cancer
2017 ►
-
Vera-Badillo Francisco Emilio; Napoleone Marc; Krzyzanowska Monika K.; Alibhai Shabbir M.; Chan An-Wen; Ocaña Alberto; Šeruga Boštjan; Templeton Arnoud J.; Amir Eitan; Tannock Ian
Bias in reporting of randomised clinical trials in oncology
2016 ►
-
Templeton Arnoud J.; Díez-González Laura; Vera-Badillo Francisco Emilio; Tibau Martorell Ariadna; Goldstein Robyn; Šeruga Boštjan; Srikanthan Amirrtha; Pandiella Atanasio; Amir Eitan; Ocaña Alberto
Interaction between hormonal receptor status, age and survival in patients with BRCA1/2 germline mutations
2016 ►
-
Tibau Martorell Ariadna; Ocaña Alberto; Anguera Geòrgia; Šeruga Boštjan; Templeton Arnoud J.; Barnadas Agustí; Amir Eitan
Oncologic drugs advisory committee recommendations and approval of cancer drugs by the US Food and Drug Administration
2016 ►
-
Al Hashem Hashem Yashem; Al-Mubarak Mustafa; Vera-Badillo Francisco Emilio; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Amir Eitan
Impact of geographic region on benefit of approved anticancer drugs evaluated in international phase III clinical trials
2016 ►
-
Ocaña Alberto; Díez-González Laura; Garcia-Olmo D. C.; Templeton Arnoud J.; Vera-Badillo Francisco Emilio; Gascón-Escribano María J.; Serrano-Heras G.; Corrales-Sánchez Verónica; Šeruga Boštjan; Andrés-Pretel F.; Pandiella Atanasio; Amir Eitan
Circulating DNA and survival in solid tumors
2016 ►
-
Ocaña Alberto; Pérez-Peña Javier; Díez-González Laura; Corrales-Sánchez Verónica; Templeton Arnoud J.; Šeruga Boštjan; Amir Eitan; Pandiella Atanasio
Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer
2016 ►
-
Ocaña Alberto; Ethier Josee-Lyne; Díez-González Laura; Corrales-Sanchez Verónica; Srikanthan Amirrtha; Gascón-Escribano María J.; Templeton Arnoud J.; Vera-Badillo Francisco Emilio; Šeruga Boštjan; Niraula Saroj; Pandiella Atanasio; Amir Eitan
Influence of companion diagnostics on efficacy and safety of targeted anti-cancer drugs
2015 ►
-
Srikanthan Amirrtha; Vera-Badillo Francisco Emilio; Ethier Josee-Lyne; Goldstein Robyn; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Amir Eitan
Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies
2016 ►
-
Žist Andrej; Amir Eitan; Ocaña Alberto; Šeruga Boštjan
Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel
2015 ►
-
Šeruga Boštjan; Ocaña Alberto; Amir Eitan; Tannock Ian
Failures in phase III
2015 ►
-
Ocaña Alberto; Šeruga Boštjan; Amir Eitan
Pathological complete response in breast cancer
2015 ►
-
Tibau Martorell Ariadna; Ocaña Alberto; Šeruga Boštjan; Templeton Arnoud J.; Barnadas Agustí; Amir Eitan
Association between Oncologic Drugs Advisory Committee (ODAC) members' financial conflicts of interest (FCOIs) and recommendations for drug approval by the U.S. Food and Drug Administration (FDA)
2015 ►
-
Amir Eitan; Al-Mubarak Mustafa; Tibau Martorell Ariadna; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan
Extended adjuvant tamoxifen for early breast cancer
2013 ►
-
Vera-Badillo Francisco Emilio; Chang Martin; Kuruzar Gordana; Ocaña Alberto; Templeton Arnoud J.; Šeruga Boštjan; Goldstein Robyn; Bedard Philippe L.; Tannock Ian; Amir Eitan
Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer
2015 ►
-
Niraula Saroj; Amir Eitan; Vera-Badillo Francisco Emilio; Šeruga Boštjan; Ocaña Alberto; Tannock Ian
Risk of incremental toxicities and associated costs of new anticancer drugs
2014 ►
-
Al Hashem Hashem Yashem; Al-Mubarak Mustafa; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Amir Eitan
Impact of geographic region on benefit of anticancer agents evaluated in international phase III clinical trials
2014 ►
-
Tibau B.; Bedard Philippe L.; Vera-Badillo Francisco Emilio; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Barnadas Agustí; Amir Eitan
Author financial conflicts of interest (FCOIs) in clinical practice guidelines (CPGs) for systemic anti-cancer drugs
2014 ►
-
Srikanthan Amirrtha; Ethier Josee-Lyne; Ocaña Alberto; Šeruga Boštjan; Krzyzanowska Monika K.; Amir Eitan
Cardiovascular toxicity of multi-tyrosine kinase inhibitors in advanced solid tumors
2015 ►
-
Templeton Arnoud J.; Diez-Gonzales Laura; Ace Olga; Vera-Badillo Francisco Emilio; Šeruga Boštjan; Jordán Joaquín; Amir Eitan; Pandiella Atanasio; Ocaña Alberto
Prognostic relevance of receptor tyrosine kinase expression in breast cancer
2014 ►
-
Tibau Ariadna; Bedard Philippe L.; Srikanthan Amirrtha; Ethier Josee-Lyne; Vera-Badillo Francisco Emilio; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Barnadas Agustí; Amir Eitan
Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs
2015 ►
-
Niraula Saroj; Amir Eitan; Vera-Badillo Francisco Emilio; Šeruga Boštjan; Ocaña Alberto; Tannock Ian
Risk of incremental toxicities and associated costs of new anticancer drugs
2014 ►
-
Vera-Badillo Francisco Emilio; Chang Martin; Kuruzar Gordana; Ocaña Alberto; Templeton Arnoud J.; Šeruga Boštjan; Al-Mubarak Mustafa; Goldstein Robyn; Bedard Philippe L.; Tannock Ian; Amir Eitan
Association between androgen receptor (AR) expression, Ki-67, and the 21-gene recurrence score in early breast cancer
2014 ►
-
Vera-Badillo Francisco Emilio; Napoleone Marc; Ocaña Alberto; Templeton Arnoud J.; Šeruga Boštjan; Al-Mubarak Mustafa; Al Hashem Hashem Yashem; Tannock Ian; Amir Eitan
Effect of multifocality and multicentricity on outcome in early breast cancer
2014 ►
-
Niraula Saroj; Amir Eitan; Vera-Badillo Francisco Emilio; Šeruga Boštjan; Ocaña Alberto; Tannock Ian
Absolute risk and cost of management of toxicities of newly approved anticancer drugs
2014 ►
-
Ocaña Alberto; Vera-Badillo Francisco Emilio; Al-Mubarak Mustafa; Templeton Arnoud J.; Corrales-Sanchez Verónica; Diez-Gonzales Laura; Cuenca-Lopez Mária D.; Šeruga Boštjan; Pandiella Atanasio; Amir Eitan
Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors
2014 ►
-
Vera-Badillo Francisco Emilio; Napoleone Marc; Ocaña Alberto; Templeton Arnoud J.; Šeruga Boštjan; Al-Mubarak Mustafa; Al Hashem Hashem Yashem; Tannock Ian; Amir Eitan
Effect of multifocality and multicentricity on outcome in early stage breast cancer
2014 ►
-
Šeruga Boštjan; Zadnik Vesna; Grašič-Kuhar Cvetka; Marinko Tanja; Čufer Tanja; Zakotnik Branko; Zorman Darko; Ocaña Alberto; Amir Eitan
Association of aromatase inhibitors with coronary heart disease in women with early breast cancer
2014 ►
-
Amir Eitan; Carlsson Lindsay; Šeruga Boštjan; Ocaña Alberto; Goodwin P. J.
A meta-analysis of the association of blood levels of vitamin-D and the risk of breast cancer
2011 ►
-
Amir Eitan; Šeruga Boštjan; Ocaña Alberto; Carlsson Lindsay; Bedard Philippe L.
Pooled analysis of outcomes of T1a/bN0, HER2-amplified breast cancer
2011 ►
-
Niraula Saroj; Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Tannock Ian
The balance between benefits and harms of molecular targeted agents
2011 ►
-
Al-Mubarak Mustafa; Tibau Ariadna; Templeton Arnoud J.; Cescon David W.; Ocaña Alberto; Šeruga Boštjan; Amir Eitan
Extended adjuvant tamoxifen for early breast cancer
2014 ►
-
Horgan Anne M.; Šeruga Boštjan; Pond Gregory Russell; Alibhai Shabbir M.; Amir Eitan; De Wit Ronald; Eisenberger Mario A.; Tannock Ian
Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial
2014 ►
-
Vera-Badillo Francisco; Templeton Arnoud J.; Gouveia Paulo de; Diaz-Padilla Ivan; Bedard Philippe L.; Al-Mubarak Mustafa; Šeruga Boštjan; Tannock Ian; Ocaña Alberto; Amir Eitan
Androgen receptor expression and outcomes in early breast cancer
2013 ►
-
Templeton Arnoud J.; McNamara M. G.; Vera-Badillo Francisco; Aneja P.; Ocaña Alberto; Šeruga Boštjan; Leibowitz-Amit R.; Knox Jennifer J; Amir Eitan
Prognostic role of neutrophil to lymphocyte ratio (nlr) in solid tumors
2013 ►
-
Šeruga Boštjan; Zadnik Vesna; Grašič-Kuhar Cvetka; Marinko Tanja; Zorman Darko; Čufer Tanja; Zakotnik Branko; Ocaña Alberto; Amir Eitan
Aromatase inhibitors and cardiac outcomes in women undergoing cardiac angiography after early breast cancer
2012 ►
-
Žist Andrej; Amir Eitan; Ocaña Alberto; Šeruga Boštjan
Impact of comorbidity on outcome in men with metastatic castrate-resistant prostate cancer (mCRPC)
2013 ►
-
Vera-Badillo Francisco; Templeton Arnoud J.; Gouveia Paulo de; Diaz-Padilla Ivan; Bedard Philippe L.; Al-Mubarak Mustafa; Šeruga Boštjan; Tannock Ian; Ocaña Alberto; Amir Eitan
Androgen receptor expression and outcomes in early breast cancer
2014 ►
-
Ocaña Alberto; Vera-Badillo Francisco; Šeruga Boštjan; Pandiella Atanasio; Amir Eitan
Meta-analysis of HER3 expression and prognosis in solid tumors
2012 ►
-
Niraula Saroj; Šeruga Boštjan; Ocaña Alberto; Shao Tiffany; Goldstein Robyn; Tannock Ian; Amir Eitan
The price we pay for progress
2012 ►
-
Ocaña Alberto; Amir Eitan; Vera-Badillo Francisco; Šeruga Boštjan; Tannock Ian
Phase III trials of targeted anticancer therapies
2013 ►
-
Al-Mubarak Mustafa; Sacher Adrian G.; Ocaña Alberto; Vera-Badillo Francisco; Šeruga Boštjan; Amir Eitan
Fulvestrant for advanced breast cancer
2013 ►
-
Šeruga Boštjan; Amir Eitan; Tannock Ian
Hormonal anticancer treatment in the senior cancer patient
2010 ►
-
Ocana Alberto; Vera-Badillo Francisco; Šeruga Boštjan; Templeton Arnoud; Pandiella Atanasio; Amir Etian
HER3 overexpression and survival in solid tumors: a meta-analysis
2013 ►
-
Templeton Arnoud; Ocaña Alberto; Šeruga Boštjan; Vera-Badillo Francisco; Carlsson Lindsay; Bedard Philippe L.; Amir Eitan
Management of small HER2 overexpressing tumours
2012 ►
-
Amir Eitan; Bedard Philippe L.; Ocaña Alberto; Šeruga Boštjan
Benefits and harms of detecting clinically occult breast cancer
2012 ►
-
Ocaña Alberto; Amir Eitan; Šeruga Boštjan; Martin Miguel; Pandiella Atanasio
The evolving landscape of protein kinases in breast cancer: clinical implications
2013 ►
-
Šeruga Boštjan; Pond Gregory Russell; Hertz Paul C; Amir Eitan; Ocaña Alberto; Tannock Ian
Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods
2012 ►
-
Amir Eitan; Šeruga Boštjan; Freedman Orit; Clemons Mark
Amenorrhoea, menopause, and endocrine therapy for breast cancer
2009 ►
-
Amir Eitan; Šeruga Boštjan; Niraula Saroj; Carlsson Lindsay; Ocaña Alberto
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis
2011 ►
-
Amir Eitan; Šeruga Boštjan; Martinez-Lopez Joaquin; Kwong Ryan; Pandiella Atanasio; Tannock Ian; Ocaña Alberto
Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs
2011 ►
-
Amir Eitan; Šeruga Boštjan; Kwong Ryan; Tannock Ian; Ocaña Alberto
Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?
2012 ►
-
Amir Eitan; Ocaña Alberto; Freedman Orit; Clemons Mark; Šeruga Boštjan
Dose-dense treatment for triple-negative breast cancer: chemotherapy
2010 ►
-
Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Josse Robert; Clemons Mark
Zoledronic acid for breast cancer therapy-induced bone loss: medical oncology
2010 ►
-
Ocaña Alberto; Amir Eitan; Šeruga Boštjan
Clinical research: show us the data
2011 ►
-
Amir Eitan; Šeruga Boštjan; Freedman Orit; Tannock Ian
Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?
2009 ►
-
Šeruga Boštjan; Amir Eitan; Tannock Ian
Treatment of lung cancer
2009 ►
-
Amir Eitan; Šeruga Boštjan; Serrano Rosario; Ocaña Alberto
Targeting DNA repair in breast cancer: a clinical and translational update
2010 ►
-
Amir Eitan; Freedman Orit C; Šeruga Boštjan; Evans Gareth D
Assessing women at high risk of breast cancer ea review of risk assessment models
2010 ►
-
Šeruga Boštjan; Ocaña Alberto; Niraula Saroj; Amir Eitan
Absolute benefits of aromatase inhibitors in adjuvant treatment of breast cancer: should we know more?
2010 ►
-
Ocaña Alberto; Amir Eitan; Šeruga Boštjan
Do we have to change the way targeted drugs are developed?
2010 ►
-
Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Freedman Orit; Clemons Mark
Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancer
2010 ►
-
Šeruga Boštjan; Amir Eitan
Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis
2010 ►
-
Amir O; Kar B; Delgado RM; Younis AG; Gregorič ID; Smart FW; Radovančević B; Frazier OH
Images in cardiovascular medicine. High left ventricular assist device flows resulting from combined native aortic valve and outflow valve regurgitation
2005 ►
-
Amir O; Delgado RM; Kar B; Gregorič I; Radovancevic B; Smart F; Cohn W
Recovery from multi-organ failure in a patient with a continuous-flow left ventricular assist device
2005 ►
-
Amir Offer; Smith Ronald; Nishikawa Akaira; Gregorič Igor D; Smart Frank W
Left ventricular free wall rupture in acute myocardial infarction: a case report and literature review
2005 ►
-
Amir O; Delgado RM; Kar B; Gregorič ID; Radovančević B; Smart F; Cohn W
Recovery from multi-organ failure in a patient with a continuous-flow left ventricular assist device
2006 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics